The US Food and Drug Administration (FDA) last night (Friday) approved the use of Pfizer and BioNTech’s corona vaccine for children ages 5 to 11, a move that would make it possible to vaccinate about 28 million children in the United States. One-third of the adult dose, and was also determined to be safe and effective in preventing infection and morbidity in the corona.
The Center for Disease Control and Prevention will have to finally approve this before the vaccines can be given. The decision was made for a meeting of an advisory committee to examine the doses for children next week, and immediately after that a public distribution of the vaccines is expected.
FDA approval – which was expected – came after the agency’s advisory committee on vaccines and related biological products overwhelmingly voted on Tuesday that the dose of Pfizer vaccine for children would be lower.
Pfizer conducted an experiment with about 3,000 vaccinated compared to a smaller control group of unvaccinated. The vaccine has been found to be 90% effective in preventing symptomatic disease and has been found to raise the levels of neutralizing antibodies against the corona delta delta, to the same level they are found in newly vaccinated 16-25 year olds, even though the dose received by children was lower. No serious side effects to the vaccine were found in the experiment.
According to estimates, the Ministry of Health will also approve the vaccine in Israel.